It may not be tempting to buy stocks that have tumbled recently; it often feels safer and more rewarding to invest in stocks as they climb and smile as they reach new highs week after week. But if you plan to invest for the long term, your best move may be to invest in a stock that's struggling today -- because you'll buy at a reasonable price and benefit as the company potentially goes on to reco...
It may not be tempting to buy stocks that have tumbled recently; it often feels safer and more rewarding to invest in stocks as they climb and smile as they reach new highs week after week. But if you plan to invest for the long term, your best move may be to invest in a stock that's struggling today -- because you'll buy at a reasonable price and benefit as the company potentially goes on to recover and win. Investing for the long term implies holding a stock for at least five years, and doing this is a great idea as it allows you to maximize your gain as a company recovers and/or grows. It also means you can get in on quality players when they're down and don't have to worry about whether it will take them a while to bounce back. Finally, when you're in it for the long term, short-term market disturbances won't feel overly intimidating. With all of this in mind, if you have $500 or even a bit less, here are two healthcare stocks long-term investors should buy right now. Continue reading
PhonlamaiPhoto/iStock via Getty Images Investment Thesis iShares US Medical Devices ETF ( IHI ) warrants a Buy rating due to its selloff driven by short-term concerns and the innovative growth potential of its top holdings. Specifically, IHI's top holdings are industry leaders in medical equipment that are positioned to capture increasing demand, thereby driving capital appreciation and dividend g...
PhonlamaiPhoto/iStock via Getty Images Investment Thesis iShares US Medical Devices ETF ( IHI ) warrants a Buy rating due to its selloff driven by short-term concerns and the innovative growth potential of its top holdings. Specifically, IHI's top holdings are industry leaders in medical equipment that are positioned to capture increasing demand, thereby driving capital appreciation and dividend growth. While the ETF's overall valuation remains high relative to broad healthcare funds, this short-term pullback presents an opportunity to capture long-term demand in medical robotics, wearables, and minimally invasive procedures. iShares U.S. Medical Devices ETF - Overview and Compared ETFs IHI is an ETF that passively tracks an index that captures U.S. companies that specialize in the manufacturing and distribution of medical devices . With its inception in 2006, the fund has 47 holdings and $3.26B in AUM. I wrote on IHI about two years ago and rated the fund a buy. Despite the fund's share price decline since then, I am still convinced that IHI's fundamental strengths remain. For comparison purposes, other funds examined are State Street SPDR S&P Health Care Equipment ETF ( XHE ), Invesco S&P SmallCap Health Care ETF ( PSCH ), and Vanguard Health Care ETF ( VHT ). XHE uses a modified equal-weight index to capture large, mid, and small-cap companies that focus on health care equipment and supplies. PSCH broadly captures healthcare companies but tracks a float-adjusted, market-cap-weighted index that captures small-cap companies. VHT is the most diversified fund compared and broadly captures the U.S. healthcare sector. IHI Compared: Performance, Expense Ratio, and Dividend Yield IHI has seen an average annual return over the past 10 years of 12.22%. By comparison, XHE and PSCH have been the worst performing funds historically, with 10-year average annual returns of 8.36% and 7.76%, respectively. VHT has been another strong performing fund with an average 10-year annual ...
Michelle Smith/iStock via Getty Images Working as an analyst in the wealth management segment, I realize that seeing ETFs like the Calamos Autocallable Inc ETF ( CAIE ), which in a synthetic way manage to make instruments like autocallables available to the common retail, is a major step forward in the field of financial engineering. In my experience, they are typically included in fairly wealthy ...
Michelle Smith/iStock via Getty Images Working as an analyst in the wealth management segment, I realize that seeing ETFs like the Calamos Autocallable Inc ETF ( CAIE ), which in a synthetic way manage to make instruments like autocallables available to the common retail, is a major step forward in the field of financial engineering. In my experience, they are typically included in fairly wealthy client segments (above HNW), which is why I followed the launch of Calamos Advisors LLC with great interest. Especially because we are still talking about instruments that today have been able to distribute over 10% TTM, competing with many other categories highly appreciated by modern income investors (such as buy-write ETFs). And the question I, personally, asked myself was, is the typical trade-off of an autocallable between risk and return really a distinctive element compared to other income instruments? My attention turned especially to buy-write ETFs, which, while presenting a payoff (although different in structural terms), in my opinion, are similar from a scenario perspective. And the answer may be surprising. But first… A Necessary Introduction Calamos Advisors LLC is the issuer of CAIE: I start from this because here the manager has a much more relevant role compared to a traditional ETF. Personally, I consider it an asset manager with strong structuring and financial innovation capabilities, able to bring complex OTC products into ETF format (not at all trivial). CAIE is, in fact, an active, alternative ETF based on derivatives and autocallable structures: they are neither equity ETFs nor bond ETFs. In other words, a product closer to an options strategy than to a classic ETF. In this sense, I want to clarify that the investor is not buying a simple ETF but is implicitly relying on the manager’s ability to build and maintain a complex derivative structure . And it is important because the fund was launched in mid-2025, so it also has a fairly limited track reco...
South Korean AI startup Upstage is in advanced talks with AMD (NasdaqGS:AMD) to purchase 10,000 MI355 AI accelerators. The potential deal would expand AMD’s presence in the Korean and broader Asian AI chip market. Upstage is seeking to diversify its supply chain away from Nvidia for major AI projects in South Korea. For investors following NasdaqGS:AMD, this potential order highlights how AI infra...
South Korean AI startup Upstage is in advanced talks with AMD (NasdaqGS:AMD) to purchase 10,000 MI355 AI accelerators. The potential deal would expand AMD’s presence in the Korean and broader Asian AI chip market. Upstage is seeking to diversify its supply chain away from Nvidia for major AI projects in South Korea. For investors following NasdaqGS:AMD, this potential order highlights how AI infrastructure demand is spreading across regions and vendors. AMD already competes in CPUs, GPUs, and data center accelerators, and interest from an AI startup focused on large scale deployments in South Korea suggests that buyers are seeking more than one option for high performance compute. If these talks result in a firm order, it could serve as a reference point for AMD in other Asian AI buildouts and national programs. Investors watching AMD may use deals like this to assess how its newer accelerators are being adopted by AI focused customers that are actively scaling their infrastructure. Stay updated on the most important news stories for by adding it to your or . Alternatively, explore our to discover new perspectives on Advanced Micro Devices. NasdaqGS:AMD Earnings & Revenue Growth as at Mar 2026 The potential Upstage order plugs neatly into AMD’s push to become a system-level AI supplier rather than just a chip vendor. Upstage is competing in South Korea’s state-backed race to build national AI foundation models and is looking to diversify away from Nvidia, which indicates that buyers on the front line of AI training want a second source for high-performance accelerators. A 10,000-unit MI355 order would be meaningful as a proof point for AMD’s Instinct GPU family in Asia and would sit alongside recent moves such as the Samsung HBM4 agreement and the Helios rack-scale platform with Celestica, which both aim to support large AI clusters. Advertisement How This Fits Into The Advanced Micro Devices Narrative The talks with Upstage support the AI data center catalyst in th...
TLDR AMD is in talks to sell 10,000 MI355 AI chips to South Korean startup Upstage. AMD CEO Lisa Su met Upstage CEO Sung Kim in Seoul last week to discuss the deal. Upstage wants to diversify away from Nvidia, which dominates Korea’s AI chip supply. Upstage is competing in a government-backed AI tournament nicknamed the “AI Squid Game.” The company is building a 200-billion-parameter AI model ahea...
TLDR AMD is in talks to sell 10,000 MI355 AI chips to South Korean startup Upstage. AMD CEO Lisa Su met Upstage CEO Sung Kim in Seoul last week to discuss the deal. Upstage wants to diversify away from Nvidia, which dominates Korea’s AI chip supply. Upstage is competing in a government-backed AI tournament nicknamed the “AI Squid Game.” The company is building a 200-billion-parameter AI model ahead of a summer evaluation round. 💥 Find the Next KnockoutStock! Get live prices, charts, and KO Scores from KnockoutStocks.com , the data-driven platform ranking every stock by quality and breakout potential. AMD is in talks to supply 10,000 of its MI355 AI accelerators to South Korean AI startup Upstage — a deal that could mark one of the chipmaker’s bigger wins in Asia’s booming AI market. Korean AI startup Upstage is in discussions with AMD to buy 10,000 of its latest AI accelerators as part of an effort to bring large-scale compute into the country https://t.co/PmSjPo7i85 — Bloomberg (@business) March 23, 2026 Upstage CEO Sung Kim confirmed the discussions after meeting AMD CEO Lisa Su in Seoul last week. “We have a lot of Nvidia chips in Korea, but we want to diversify to other chips, including AMD’s,” Kim told Bloomberg Television on Monday. Advanced Micro Devices, Inc., AMD The talks come as demand for AI computing power continues to climb across Asia, and concerns around Nvidia’s supply and pricing push companies to look at alternatives. For AMD, landing a 10,000-chip order would be more than a sales number. It would be a foothold in a market where Nvidia currently dominates. AMD Challenges Nvidia’s Grip in Korea Upstage is one of four teams in a state-backed competition to build South Korea’s top national AI model. The contest — nicknamed the “AI Squid Game” after the Netflix show — is run under oversight from South Korea’s Ministry of Science and ICT. Teams are evaluated every six months and the strongest performers earn access to more high-end Nvidia GPUs. South K...
JHVEPhoto Deputy Secretary of Defense Steve Feinberg said in a letter to Pentagon leaders that Palantir’s ( PLTR ) Maven AI system will become an official program of record, Reuters reported. In the March 9 letter to senior Pentagon leaders and U.S. military commanders, Feinberg said that embedding Palantir’s Maven Smart System would provide warfighters "with the latest tools necessary to detect,...
JHVEPhoto Deputy Secretary of Defense Steve Feinberg said in a letter to Pentagon leaders that Palantir’s ( PLTR ) Maven AI system will become an official program of record, Reuters reported. In the March 9 letter to senior Pentagon leaders and U.S. military commanders, Feinberg said that embedding Palantir’s Maven Smart System would provide warfighters "with the latest tools necessary to detect, deter, and dominate our adversaries in all domains." The move would lock in long-term use of the company's weapons-targeting technology in the U.S. military, the report added . The decision is anticipated to go into effect by the end of the current fiscal year, which ends in September, the report noted. Maven is a command-and-control software platform for the U.S. military that fuses data from satellites, drones, and sensors into a single interface for battlefield analysis and threat identification. Feinberg said designating Maven as a program of record will streamline its adoption in all areas of the military and provide stable, long-term funding. The memo ordered oversight of Maven to be moved from the National Geospatial Intelligence Agency to the Pentagon’s Chief Digital Artificial Intelligence Office within 30 days. The letter noted that future contracting with Palantir will be handled by the Army, according to the report. “It is imperative that we invest now and with focus to deepen the integration of artificial intelligence (AI) across the Joint Force and establish AI-enabled decision-making as the cornerstone of our strategy,” said Feinberg. The Department of War and Palantir did not immediately respond to a request for comment from Seeking Alpha. Palantir — which provides AI and data analytics software platforms like Gotham and Foundry to intelligence agencies — is a major contractor for the U.S. government and last year in August secured a $10B contract with the Army. Earlier this month, during a presentation at a Palantir event, Pentagon official Cameron Stan...
JHVEPhoto Deputy Secretary of Defense Steve Feinberg said in a letter to Pentagon leaders that Palantir’s ( PLTR ) Maven AI system will become an official program of record, Reuters reported. In the March 9 letter to senior Pentagon leaders and U.S. military commanders, Feinberg said that embedding Palantir’s Maven Smart System would provide warfighters "with the latest tools necessary to detect,...
JHVEPhoto Deputy Secretary of Defense Steve Feinberg said in a letter to Pentagon leaders that Palantir’s ( PLTR ) Maven AI system will become an official program of record, Reuters reported. In the March 9 letter to senior Pentagon leaders and U.S. military commanders, Feinberg said that embedding Palantir’s Maven Smart System would provide warfighters "with the latest tools necessary to detect, deter, and dominate our adversaries in all domains." The move would lock in long-term use of the company's weapons-targeting technology in the U.S. military, the report added . The decision is anticipated to go into effect by the end of the current fiscal year, which ends in September, the report noted. Maven is a command-and-control software platform for the U.S. military that fuses data from satellites, drones, and sensors into a single interface for battlefield analysis and threat identification. Feinberg said designating Maven as a program of record will streamline its adoption in all areas of the military and provide stable, long-term funding. The memo ordered oversight of Maven to be moved from the National Geospatial Intelligence Agency to the Pentagon’s Chief Digital Artificial Intelligence Office within 30 days. The letter noted that future contracting with Palantir will be handled by the Army, according to the report. “It is imperative that we invest now and with focus to deepen the integration of artificial intelligence (AI) across the Joint Force and establish AI-enabled decision-making as the cornerstone of our strategy,” said Feinberg. The Department of War and Palantir did not immediately respond to a request for comment from Seeking Alpha. Palantir — which provides AI and data analytics software platforms like Gotham and Foundry to intelligence agencies — is a major contractor for the U.S. government and last year in August secured a $10B contract with the Army. Earlier this month, during a presentation at a Palantir event, Pentagon official Cameron Stan...
Japan’s top government spokesperson said on Monday that one of two Japanese nationals detained in Iran has safely returned home in good health. Chief Cabinet Secretary Minoru Kihara’s confirmation came one day after Foreign Minister Toshimitsu Motegi announced the person’s release. Motegi, speaking on a Fuji Television talk show on Sunday, said the person had been detained since last year and was ...
Japan’s top government spokesperson said on Monday that one of two Japanese nationals detained in Iran has safely returned home in good health. Chief Cabinet Secretary Minoru Kihara’s confirmation came one day after Foreign Minister Toshimitsu Motegi announced the person’s release. Motegi, speaking on a Fuji Television talk show on Sunday, said the person had been detained since last year and was released on Wednesday. Advertisement He said the person took a flight from Azerbaijan. Kihara, at a regular press conference on Monday, confirmed that the former detainee returned to Japan on Sunday in good health. Trump’s talks with Japanese Prime Minister Sanae Takaichi off to positive start Trump’s talks with Japanese Prime Minister Sanae Takaichi off to positive start Kihara said another Japanese national who was arrested earlier this year is still in custody but “we have confirmed that there is no problem with the safety and health” of the person and that Japan is continuing to press Iran for a release as soon as possible.